Poland
# |
Name |
Goodwill |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 247.30 M
|
Dec. 31, 2023 | USD 208.13 | 0.81% |
|
Poland |
|
2 |
USD 18.27 M
|
Dec. 31, 2023 | USD 10.78 | -0.36% |
|
Poland |
|
3 |
USD 15.54 M
|
Dec. 31, 2023 | USD 36.63 | -0.24% |
|
Poland |
|
4 |
USD 6.79 M
|
Dec. 31, 2023 | USD 2.85 | 0.09% |
|
Poland |
|
5 |
USD 1.29 M
|
Dec. 31, 2023 | USD 0.90 | -1.27% |
|
Poland |
|
6 |
USD 766.60 K
|
Dec. 31, 2023 | USD 5.15 | -3.61% |
|
Poland |
|
7 |
USD 0.00
|
Dec. 31, 2023 | USD 1.88 | 0.22% |
|
Poland |
|
8 |
USD 0.00
|
Dec. 31, 2023 | USD 2.29 | -0.01% |
|
Poland |
|
9 |
USD 0.00
|
Dec. 31, 2023 | USD 3.74 | 1.10% |
|
Poland |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 1.15 | -0.76% |
|
Poland |
|
11 |
USD 0.00
|
Dec. 31, 2023 | USD 9.53 | -0.94% |
|
Poland |
|
12 |
USD 0.00
|
Dec. 31, 2023 | USD 6.78 | -1.52% |
|
Poland |
|
13 |
USD 0.00
|
Dec. 31, 2023 | USD 40.34 | 2.10% |
|
Poland |
|
14 |
USD 0.00
|
Sept. 30, 2024 | USD 58.16 | 0.74% |
|
Poland |
|
15 |
USD 0.00
|
Dec. 31, 2023 | USD 1.23 | 1.32% |
|
Poland |
|
16 |
USD 0.00
|
Dec. 31, 2023 | USD 5.95 | -0.32% |
|
Poland |
|
17 |
USD 0.00
|
Dec. 31, 2023 | USD 21.83 | 2.30% |
|
Poland |
|
18 |
USD 0.00
|
Dec. 31, 2023 | USD 12.77 | 1.67% |
|
Poland |
|
19 |
USD 0.00
|
Dec. 31, 2023 | USD 1.78 | -1.14% |
|
Poland |
The Biotechnology company in Poland with the highest Goodwill is NEUCA S.A. (Warsaw Stock Exchange: NEU.WA) at USD 247.30 M.
The Biotechnology company in Poland with the lowest Goodwill is Genomtec S.A. (Warsaw Stock Exchange: GMT.WA) at USD 0.00.
The top 10 Biotechnology companies in Poland by Goodwill are NEUCA S.A., Selvita S.A., Voxel S.A., EMC Instytut Medyczny SA, BIOTON S.A., Centrum Medyczne ENEL-MED S.A., Medinice S.A., Mabion S.A., BioMaxima S.A. and Pharmena S.A..
The bottom 10 Biotechnology companies in Poland by Goodwill are Genomtec S.A., Captor Therapeutics Spolka Akcyjna, Bioceltix S.A., Celon Pharma S.A., Synthaverse S.A., Synektik Spólka Akcyjna, Scope Fluidics S.A., Ryvu Therapeutics S.A., Poltreg S.A. and Pharmena S.A..